Currently out of the existing stock ratings of Amy Li, 4 are a BUY (100%).

Amy Li

Work Performance Price Targets & Ratings Chart

Analyst Amy Li, currently employed at JEFFERIES, carries an average stock price target met ratio of 75% that have a potential upside of 28.92% achieved within 75 days.

Amy Li’s has documented 8 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LQDA, Liquidia Technologies at 13-Jan-2026.

Wall Street Analyst Amy Li

Analyst best performing recommendations are on LQDA (LIQUIDIA TECHNOLOGIES).
The best stock recommendation documented was for IRWD (IRONWOOD PHARMACEUTICALS) at 4/15/2025. The price target of $0.7 was fulfilled within 6 days with a profit of $0.02 (2.78%) receiving and performance score of 4.63.

Average potential price target upside

BHVN Biohaven Pharmaceutical Holding Co Ltd IRWD Ironwood Pharmaceuticals LQDA Liquidia Technologies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Jun-2018

$30

$21.24 (242.47%)

$75

3 months 27 days ago
(11-Mar-2026)

3/17 (17.65%)

$19.54 (186.81%)

1348

Hold Since 26-Dec-2025

$10

$1.24 (14.16%)

$11

4 months 4 days ago
(04-Mar-2026)

4/18 (22.22%)

$-0.61 (-5.75%)

23

Buy Since 24-Jul-2024

$21

$12.24 (139.73%)

6 months 2 days ago
(06-Jan-2026)

0/6 (0%)

$11.38 (118.30%)

Buy Since 06-Feb-2024

$11

$2.24 (25.57%)

$26

7 months 12 days ago
(26-Nov-2025)

2/6 (33.33%)

$1.52 (16.03%)

26

Buy Since 04-Jan-2023

$15

$6.24 (71.23%)

$55

7 months 18 days ago
(20-Nov-2025)

6/12 (50%)

$5.37 (55.76%)

63

Show more analysts

Please expand the browser size to see the chart

Which stock is Amy Li is most bullish on?

Potential upside of $-23.93 has been obtained for LQDA (LIQUIDIA TECHNOLOGIES)

What Year was the first public recommendation made by Amy Li?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?